Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses-Reference-Cited by-同舟云学术

Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses

Published:2019-07-02 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Mácsik-Valent Bernadett,Nagy Katinka,Fazekas László,Erdei Anna

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. The versatile functions of complement C3-derived ligands;Erdei;Immunol Rev.,2016

2. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity;Dempsey;Science.,1996

3. Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes;Jozsi;J Immunol.,2002

4. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients;Kremlitzka;Int Immunol.,2013

5. Complement receptor type 1 suppresses human B cell functions in SLE patients;Kremlitzka;J Immunol Res.,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of diagnostic signatures for ischemic stroke by machine learning algorithm;Journal of Stroke and Cerebrovascular Diseases;2024-03

2. Targeted suppression of Dpt‐specific B cells in humanized Rag2‐ γc‐ mouse model of HDM allergy;Scandinavian Journal of Immunology;2022-12-24

3. Selective Silencing of Disease-Associated B Lymphocytes from Hashimoto’s Thyroiditis Patients by Chimeric Protein Molecules;International Journal of Molecular Sciences;2022-12-01

4. Label-free real-time monitoring of the BCR-triggered activation of primary human B cells modulated by the simultaneous engagement of inhibitory receptors;Biosensors and Bioelectronics;2021-11

5. New aspects in the regulation of human B cell functions by complement receptors CR1, CR2, CR3 and CR4;Immunology Letters;2021-09